62.73 -0.13 (-0.21%)
After hours: 4:26PM EDT
|Bid||62.59 x 900|
|Ask||62.90 x 900|
|Day's Range||61.68 - 63.92|
|52 Week Range||46.01 - 99.95|
|Beta (5Y Monthly)||0.78|
|PE Ratio (TTM)||21.56|
|Earnings Date||Apr 29, 2020 - May 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||122.50|
To the annoyance of some shareholders, Integer Holdings (NYSE:ITGR) shares are down a considerable 30% in the last...
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Integer Holdings (ITGR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Zacks Analyst Blog Highlights: AAON, Business First, Himax Technologies, Integer Holdings and The Simply Good Foods Company
Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales.
Integer Holdings Corporation (“Integer”) (ITGR) announced today that Peter H. Soderberg, after 18 years of service, has decided to retire from Integer’s Board of Directors at the conclusion of his term following the Company’s annual meeting of stockholders on May 20, 2020. “On behalf of the stockholders and the entire Board, I thank Peter for his many years of dedication and service to Integer.”
Cardionomic Inc. raised money from a pool of investors including VC giant New Enterprise Associates and the Cleveland Clinic.
PLANO, Texas, Feb. 24, 2020 -- Integer Holdings Corporation (“Integer”) (NYSE:ITGR) today announced that Joseph Dziedzic, president and chief executive officer and Tony.
~ Strong 2019 Results from Strategy and Operational Execution ~~ Full Year GAAP: Sales up 4% and EPS up 92% ~~ Full Year Adjusted: Sales up 4%, EBITDA up 9%, and EPS up 23% ~.
Integer Holdings Corporation (“Integer”) (ITGR), a leading medical device outsource manufacturer, today announced it has acquired Inomec, formally establishing its presence in Israel. The acquisition enables Integer to create a research and development and sales center in the region, and adds important catheter design, clinical, and pilot manufacturing capabilities to its extensive portfolio, further positioning the company as a partner of choice for innovative medical technologies. “Acquiring Inomec strengthens our research and development pipeline by adding differentiated capabilities and expanding our global footprint in a key market with an extensive innovation ecosystem that is widely recognized as a leader in MedTech innovation.” said Joe Dziedzic, Integer president and CEO.
Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales. However, intense competition remains a woe.
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
PLANO, Texas, Jan. 24, 2020 -- Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, today announced it has established.
PLANO, Texas, Jan. 16, 2020 -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and.
Today we are going to look at Integer Holdings Corporation (NYSE:ITGR) to see whether it might be an attractive...
At the same time Moody's affirmed the Caa1 Corporate Family Rating (CFR) and Caa1-PD Probability of Default Rating, the B3 rating of the company's senior secured first lien credit facilities and the Caa3 rating of the second lien term loan. The outlook revision reflects a material improvement of Viant's liquidity as the company now has access to substantially all of its $70 million revolving credit facility. While Viant's liquidity has improved as a result of the above transaction, the company is likely to generate negative free cash flow at least until early 2020.
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
Zacks.com featured highlights include: Synaptics, Target, Medtronic Public, Bristol-Myers Squibb and Integer
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.